These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8582046)

  • 1. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
    Nakanishi H; Katsuta K; Ueda Y; Takasugi H; Kuno A; Ohkubo M; Ogita K; Yoneda Y; Shirakawa K; Yoshida K
    Psychopharmacology (Berl); 1995 Jan; 117(2):172-7. PubMed ID: 7753964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.
    Moe ST; Smith DL; DelMar EG; Shimizu SM; Van Wagenen BC; Balandrin MF; Chien YE; Raszkiewicz JL; Artman LD; White HS; Mueller AL
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2411-5. PubMed ID: 11078190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on cerebral protective agents. X. Synthesis and evaluation of anticonvulsant activities for novel 4,5,6,7-tetrahydrothieno[3,3-c]pyridines and related compounds.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):778-84. PubMed ID: 8681410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-competitive NMDA antagonists, FR115427 and MK801, enhance neuronal survival in primary culture.
    Ueda Y; Katsuta K; Nakanishi H; Yoshida K
    Neurosci Lett; 1995 Feb; 185(2):107-10. PubMed ID: 7746498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.
    Gitto R; Barreca ML; De Luca L; De Sarro G; Ferreri G; Quartarone S; Russo E; Constanti A; Chimirri A
    J Med Chem; 2003 Jan; 46(1):197-200. PubMed ID: 12502375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton.
    Gitto R; Caruso R; Pagano B; De Luca L; Citraro R; Russo E; De Sarro G; Chimirri A
    J Med Chem; 2006 Sep; 49(18):5618-22. PubMed ID: 16942035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of FR115427 against ischemic hippocampal damage in gerbils.
    Nakanishi H; Katsuta K; Koide T; Ueda Y; Shirakawa K; Yoshida K
    Jpn J Pharmacol; 1994 Mar; 64(3):189-93. PubMed ID: 8022120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.
    Folbergrová J
    Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.
    Hodgkiss JP; Sherriffs HJ; Cottrell DA; Shirakawa K; Kelly JS; Kuno A; Ohkubo M; Butcher SP; Olverman HJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):219-27. PubMed ID: 7902282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated arylcycloheptylamines.
    Sun S; Wallach J; Adejare A
    Med Chem; 2014; 10(8):843-52. PubMed ID: 24773376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a series of γ-amino alcohols comprising an N-methyl isoindoline moiety and their evaluation as NMDA receptor antagonists.
    Müller A; Höfner G; Renukappa-Gutke T; Parsons CG; Wanner KT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5795-9. PubMed ID: 21875803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
    Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
    J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists.
    Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the binding of [3H]FR115427, a novel non-competitive NMDA receptor antagonist, to rat brain membranes.
    Sherriffs HJ; Shirakawa K; Kelly JS; Olverman HJ; Kuno A; Okubo M; Butcher SP
    Eur J Pharmacol; 1993 Nov; 247(3):319-24. PubMed ID: 8307103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.